BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21943545)

  • 1. Five-year survival for lung cancer patients managed in general hospitals.
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prudhomme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2011 Sep; 28(7):e31-8. PubMed ID: 21943545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Five year survival for lung cancer patients managed in general hospitals].
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prud'homme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2009 Jan; 26(1):37-44. PubMed ID: 19212288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department].
    Moro D; Nagy-Mignotte H; Bolla M; Colonna M; Brichon PY; Brambilla C; Schaerer R; Vrousos C
    Bull Cancer; 1997 Feb; 84(2):155-61. PubMed ID: 9180838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis, treatment, and prognosis of lung cancer in the Manche (France) (1997-1999) according to patients socioeconomic characteristics].
    Madelaine J; Guizard AV; Lefevre H; Lecarpentier MM; Launoy G
    Rev Epidemiol Sante Publique; 2002 Sep; 50(4):383-92. PubMed ID: 12442055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
    Visbal AL; Williams BA; Nichols FC; Marks RS; Jett JR; Aubry MC; Edell ES; Wampfler JA; Molina JR; Yang P
    Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
    Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
    Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos HP; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
    Anticancer Res; 2006; 26(4B):3175-81. PubMed ID: 16886653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
    Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
    Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
    Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
    Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).
    Grivaux M; Breton JL; Bombaron P; Kuntz P; Lebas FX; Mehdaoui A; Herman D; David P; Berruchon J; Delclaux B; Zureik M; Blanchon F;
    Lung Cancer; 2004 Sep; 45(3):279-87. PubMed ID: 15301868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lung cancer].
    Alexandersen O
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):407-9. PubMed ID: 11255851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
    Grivaux M; Duvert B; Ferrer-Lopez P; Hominal S; Goarant E; Brichet-Martin A; Romand P; Fournier E; Asselain B; Debieuvre D
    Rev Pneumol Clin; 2016 May; 72(3):163-70. PubMed ID: 27113617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
    Blanchon F; Grivaux M; Zureik M; Marsal L; Asselain B; Lebas FX; Orlando JP; Steenhouwer F; Benichou-Flurin M; Coƫtmeur D; Collon T; David P; Delclaux B; Piquet J
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):165-71. PubMed ID: 16788443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.